Prognostic significance of survivin and Caspase-3 immunohistochemical expression in patients with diffuse large B-cell lymphoma treated with rituximab and CHOP

Mitrović, Zdravko and Ilić, Ivana and Aurer, Igor and Bašić-Kinda, Sandra and Radman, Ivo and Dotlić, Snježana and Ajduković, Radmila and Labar, Boris (2011) Prognostic significance of survivin and Caspase-3 immunohistochemical expression in patients with diffuse large B-cell lymphoma treated with rituximab and CHOP. Pathology Oncology Research, 17 (2). pp. 243-247. ISSN 1219-4956

[img]
Preview
PDF - Accepted Version
Download (253kB) | Preview

Abstract

Survivin is an inhibitor of apoptosis whose expression may be associated with inferior outcome in patients with diffuse large B-cell lymphoma (DLBCL) treated without rituximab. Caspase-3 is the final caspase of the apoptotic cascade and its pattern of expression may also be related to patients' outcome. In this study we investigated immunohistochemical expression of survivin and caspase-3 (CPP32) in 57 patients with DLBCL treated with rituximab and CHOP (R-CHOP). According to previously published criteria, we separately analyzed correlation of different types of survivin expression with patients' outcome. Nuclear survivin was expressed in only 26% of cases, cytoplasmic survivin was expressed in 81% of cases while application of immunoreactivity scoring system yielded 58% of survivin positive cases. Caspase-3 was expressed in 77% of cases. There were no significant correlations between any type of survivin expression and response to treatment or survival of the patients. The expression of caspase-3 was also not associated with patients' outcome. We conclude that survivin and caspase-3 have no significant prognostic significance in patients with DLBCL treated with R-CHOP.

Item Type: Article
MeSH: Adolescent ; Adult ; Aged ; Antibodies, Monoclonal, Murine-Derived / administration & dosage ; Antibodies, Monoclonal, Murine-Derived / therapeutic use ; Antineoplastic Combined Chemotherapy Protocols / therapeutic use ; Biomarkers, Tumor / analysis ; Caspase 3 / biosynthesis ; Cyclophosphamide ; Doxorubicin ; Female ; Humans ; Immunohistochemistry ; Inhibitor of Apoptosis Proteins / biosynthesis ; Kaplan-Meier Estimate ; Lymphoma, Large B-Cell, Diffuse / drug therapy ; Lymphoma, Large B-Cell, Diffuse / metabolism ; Lymphoma, Large B-Cell, Diffuse / pathology ; Male ; Middle Aged ; Neoplasm Staging ; Prednisone ; Prognosis ; Rituximab ; Survivin ; Vincristine ; Young Adult
Departments: Katedra za internu medicinu
Depositing User: Marijan Šember
Status: Published
Creators:
CreatorsEmail
Mitrović, ZdravkoUNSPECIFIED
Ilić, IvanaUNSPECIFIED
Aurer, IgorUNSPECIFIED
Bašić-Kinda, SandraUNSPECIFIED
Radman, IvoUNSPECIFIED
Dotlić, SnježanaUNSPECIFIED
Ajduković, RadmilaUNSPECIFIED
Labar, BorisUNSPECIFIED
Date: June 2011
Date Deposited: 27 Oct 2010
Last Modified: 20 Apr 2020 12:38
Subjects: /
Related URLs:
URI: http://medlib.mef.hr/id/eprint/869

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year